Literature DB >> 34332230

Anxiety and depressive symptoms in U.S. Census Bureau assessments of adults: Trends from 2019 to fall 2020 across demographic groups.

Jean M Twenge1, Cooper McAllister2, Thomas E Joiner3.   

Abstract

BACKGROUND: Events from spring to fall 2020, including the COVID-19 pandemic, hate crimes, and social unrest, may have impacted mental health, particularly mood and anxiety disorders. This study compares rates of positive screens for anxiety and depressive disorders in separate U.S. national samples from 2019 and April to September 2020. The analysis includes trends within demographic groups, which have received scant attention.
METHODS: Nationally representative probability samples of U.S. adults administered by the U.S. Census Bureau (n = 1.3 million) completed the PHQ-2 screening for depressive disorder and the GAD-2 screening for anxiety disorder.
RESULTS: U.S. adults in 2020 were four times more likely to screen positive for depressive and anxiety disorders than in 2019, with the largest increases among males, 18- to 29-year-olds (for depression), Asian Americans, and parents with children in the home. Anxiety and depression rose and fell in tandem with the number of COVID-19 cases in the U.S., as well as increasing during the early June weeks of racial justice protests.
CONCLUSIONS: Screens for mood and anxiety disorders remained at elevated levels in spring, summer, and fall 2020, especially among certain groups.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Anxiety; COVID-19 pandemic; Depression

Year:  2021        PMID: 34332230     DOI: 10.1016/j.janxdis.2021.102455

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  5 in total

1.  Food Insecurity-Related Interventions and Mental Health Among US Adults During the COVID-19 Pandemic, April 2020 through August 2021.

Authors:  Hyunjung Lee; Gopal K Singh
Journal:  Public Health Rep       Date:  2022-08-20       Impact factor: 3.117

2.  Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic.

Authors:  Ronald C Kessler; Christopher J Ruhm; Victor Puac-Polanco; Irving H Hwang; Sue Lee; Maria V Petukhova; Nancy A Sampson; Hannah N Ziobrowski; Alan M Zaslavsky; Jose R Zubizarreta
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Dose Optimization of Anxiolytic Compounds Group in Valeriana jatamansi Jones and Mechanism Exploration by Integrating Network Pharmacology and Metabolomics Analysis.

Authors:  Chengbowen Zhao; Xiaojia Wei; Jianyou Guo; Yongsheng Ding; Jing Luo; Xue Yang; Jiayuan Li; Guohui Wan; Jiahe Yu; Jinli Shi
Journal:  Brain Sci       Date:  2022-04-30

Review 4.  Changes in Prevalence of Mental Illness Among US Adults During Compared with Before the COVID-19 Pandemic.

Authors:  Ronald C Kessler; Wai Tat Chiu; Irving H Hwang; Victor Puac-Polanco; Nancy A Sampson; Hannah N Ziobrowski; Alan M Zaslavsky
Journal:  Psychiatr Clin North Am       Date:  2021-11-12

5.  Population Health Metrics During the Early Stages of the COVID-19 Pandemic: Correlative Pilot Study.

Authors:  Marie A Severson; David A Cassada; Victor C Huber; Daniel D Snow; Lisa M McFadden
Journal:  JMIR Form Res       Date:  2022-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.